Watchdog unsure GPhC would have improved ‘timeliness’ of FtP cases without pandemic

The General Pharmaceutical Council’s (GPhC) timeliness in progressing fitness-to-practise (FtP) cases declined “significantly” in 2020/21 and it is unclear “whether it would have improved without the pandemic”, the Professional Standards Authority (PSA) has said.

The GPhC failed to meet three out of five FtP standards of good regulation set by the PSA

The GPhC met all the standards across four PSA categories, including education and training, the watchdog said in its annual performance review of the GPhC, published today (February 7).

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment0

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment2

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment3

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Regulation

Pharmacist warned after sending patient ‘unsolicited’ message on social media

 
• By 
 • comment

A pharmacist has been issued a warning after accessing a patient’s contact details from medical records and sending them an “unsolicited” message on social media.

‘Urgent review’ of epilepsy medicine shortages needed, say group of MPs

 
• By 
 • comment

A group of 45 cross-party MPs have signed a letter to Wes Streeting calling for “an urgent review into ongoing medication shortages”, saying that if action is not taken, the crisis will “worsen”.